){kind=logo}
Loeb & Loeb represented Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company focused on the development of chronic wound care products and cosmeceuticals, in its initial public offering of 3,000,000 Class A ordinary shares at a price of $4.00 per share, for total gross proceeds of $12 million before deducting underwriting discounts and offering expenses.
The Class A Ordinary Shares began trading on the Nasdaq Stock Market on April 10, 2025, under the ticker symbol “CUPR.” The company intends to use the net proceeds to support market expansion, research and development, brand building, infrastructure investment and general corporate matters.
The Loeb team was led by Lawrence Venick, managing partner of the firm’s Hong Kong and Beijing offices, and included Capital Markets senior counsel Ted Paraskevas, and associates Michael Tsang and Katrina Wan.
The Class A Ordinary Shares began trading on the Nasdaq Stock Market on April 10, 2025, under the ticker symbol “CUPR.” The company intends to use the net proceeds to support market expansion, research and development, brand building, infrastructure investment and general corporate matters.
The Loeb team was led by Lawrence Venick, managing partner of the firm’s Hong Kong and Beijing offices, and included Capital Markets senior counsel Ted Paraskevas, and associates Michael Tsang and Katrina Wan.
-
Managing Partner, Hong Kong and Beijing Offices -
Senior Counsel -
Associate
-
Associate